References
- Gerritsma JJ, Oomen I, Meinderts S, et al., on behalf of SCORE Consortium. Back to base pairs: what is the genetic risk for red blood cell alloimmunization. Blood Rev 2021;48:100794. doi: 10.1016/j.blre.2020.100794.
- Raos M, Zunec R, Mocibob M, Gojceta K, Lukic M, Golubic Cepulic B. Susceptible and protective HLA-DR and HLA-DQ alleles for Fya alloimmunization in the Croatian population. Transfusion 2019;58:1118–24. doi: 10.1111/trf.15087.
- Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 2019; 133:1821–30. doi: 10.1182/blood-2018-08-833962.
- Evers D, Middelburg RA, de Haas M, et al. Red-blood-cell alloimmunization in relation to antigens’ exposure and their immunogenicity: a cohort study. Lancet Haematol 2016;3:284–92. doi: 10.1016/S2352-3026(16)30019-9.
- Schonewille H, Watering LMG, Loomans DSE, Brandt A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006;46:250–6. doi: 10.1111/j.1537-2995.2006.00708.x.
- Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briet E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007;47:2066–71. doi: 10.1111/j.1537-2995.2007.01433.x.
- Ryder AB, Zimring JC, Hendrickson JE. Factors influencing RBC alloimmunization: lessons learned from murine models. Transfus Med Hemother 2014;41:406–19. doi: 10.1159/ 000368995.
- Hendrickson EJ. Recipient factors influencing red blood cell alloimmunization. ISBT Sci Ser 2020;15:194–200. doi: 10.1111/voxs.12485.
- Schonewille H, Haak HL, Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999;39:763–71. doi: 10.1046/j.1537-2995.1999.39070763.x.
- Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008;48:2069–75. doi: 10.1111/j.1537-2995.2008.01815.x.
- Stack G, Tormey CA. Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence. Transfusion 2016;56:2662–7. doi: 10.1111/trf.13704.
- Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009;49:505–12. doi: 10.1111/j.1537-2995.2008.02014.x.
- Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40:1127–31. doi: 10.1046/ j.1537-2995.2000.40091127.x.
- Reverberi R. The persistence of red cell alloantibodies. Blood Transfus 2008;6:225–34. doi: 10.2450/2008.0021-08.
- Kinder JM, Stelzer IA, Arck PC, Way SS. Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol 2017;17:483–94. doi: 10.1038/nri.2017.38.
- Verduin EP, Brand A, Watering LMG, et al. Factors associated with persistence of red blood cell antibodies in women after pregnancies complicated by fetal alloimmune hemoly tic disease treated with intrauterine transfusions. Br J Haematol 2015;168:443–51. doi: 10.1111/bjh.13130.
- Hauser RG, Esserman D, Karafin MS, et al. The evanescence and persistence of RBC alloantibodies in blood donors. Transfusion 2020;60:831–9. doi: 10.1111/trf.15718.
- Remy KE, Hall MW, Cholette J, et al. Mechanisms of red blood cell transfusion-related immunomodulation: mechanisms of RBC TRIM. Transfusion 2018;58:804–15. doi: 10.1111/ trf.14488.
- Noiret L, Slater A, Higgins JM. Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors. Transfusion 2017;57:1930–7. doi: 10.1111/trf.14157.
- Dinh A, Eliason K, Dzik W. Time interval between antibody investigations among patients who demonstrate serial red cell antibody formation. Transfusion 2019;59:738–43. doi: 10.1111/trf.15013.
- Tormey CA, Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009;114:4279–82. doi: 10.1182/ blood-2009-06-227793.
- Stack G, Tormey CA. Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures. Br J Hematol 2016;175:154–60. doi: 10.1111/bjh.14175.
- Stack G. Post-transfusion detection of RBC alloimmunization: timing is ever ything. Transfusion 2021;61:2219–22. doi: 10.1111/trf.16593.
- Sloan SR. The importance of antibody screens after transfusions. Transf usion 2016;56:2653–4. doi: 10.1111/ trf.13818.